Show simple item record

Incidence of sternocutaneous fistulas following open heart surgery in a nationwide cohort.

dc.contributor.authorSteingrímsson, Steinn
dc.contributor.authorSjögren, Johan
dc.contributor.authorGudbjartsson, Tomas
dc.date.accessioned2013-09-16T13:44:34Z
dc.date.available2013-09-16T13:44:34Z
dc.date.issued2012-08
dc.date.submitted2013-09-16
dc.identifier.citationScand. J. Infect. Dis. 2012, 44(8):623-5en_GB
dc.identifier.issn1651-1980
dc.identifier.pmid22497424
dc.identifier.doi10.3109/00365548.2012.669842
dc.identifier.urihttp://hdl.handle.net/2336/301611
dc.descriptionTo access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.en_GB
dc.description.abstractWe studied the incidence and characteristics of surgically treated sternocutaneous fistulas in a nationwide cohort of patients undergoing open heart surgery in Iceland. Between 2000 and 2010, sternocutaneous fistulas were treated surgically in 6 out of 2446 patients undergoing open heart surgery (incidence 0.25%, 95% confidence interval 0.11-0.53%). All patients were male, with a mean age of 71 ± 9 y. In addition to antibiotic treatment, debridement of the wound was performed in all cases. Staphylococcus aureus and/or coagulase-negative staphylococci were identified as pathogens in 5 cases and Candida albicans in 1. Chronic infections developed in 3 patients who were treated repeatedly, 1 of them unsuccessfully. In-hospital stay ranged from 0 to 50 days (mean 19 days). Sternocutaneous fistulas are rare, but since they may have a devastating course, increased awareness of this infectious complication of open heart surgery is important.
dc.language.isoenen
dc.publisherInforma Healthcareen_GB
dc.relation.urlhttp://dx.doi.org/10.3109/00365548.2012.669842en_GB
dc.relation.urlhttp://informahealthcare.com/doi/pdf/10.3109/00365548.2012.669842en_GB
dc.rightsArchived with thanks to Scandinavian journal of infectious diseasesen_GB
dc.subject.meshAgeden_GB
dc.subject.meshAged, 80 and overen_GB
dc.subject.meshCardiac Surgical Proceduresen_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshCutaneous Fistulaen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIncidenceen_GB
dc.subject.meshMaleen_GB
dc.subject.meshProspective Studiesen_GB
dc.subject.meshStaphylococcal Infectionsen_GB
dc.subject.meshStaphylococcus aureusen_GB
dc.subject.meshSternumen_GB
dc.subject.meshSurgical Wound Infectionen_GB
dc.titleIncidence of sternocutaneous fistulas following open heart surgery in a nationwide cohort.en
dc.typeArticleen
dc.contributor.departmentDepartment of Cardiothoracic Surgery, Landspitali University Hospital, Reykjavik, Iceland.en_GB
dc.identifier.journalScandinavian journal of infectious diseasesen_GB
dc.rights.accessLandspitali Access - LSH-aðganguren
html.description.abstractWe studied the incidence and characteristics of surgically treated sternocutaneous fistulas in a nationwide cohort of patients undergoing open heart surgery in Iceland. Between 2000 and 2010, sternocutaneous fistulas were treated surgically in 6 out of 2446 patients undergoing open heart surgery (incidence 0.25%, 95% confidence interval 0.11-0.53%). All patients were male, with a mean age of 71 ± 9 y. In addition to antibiotic treatment, debridement of the wound was performed in all cases. Staphylococcus aureus and/or coagulase-negative staphylococci were identified as pathogens in 5 cases and Candida albicans in 1. Chronic infections developed in 3 patients who were treated repeatedly, 1 of them unsuccessfully. In-hospital stay ranged from 0 to 50 days (mean 19 days). Sternocutaneous fistulas are rare, but since they may have a devastating course, increased awareness of this infectious complication of open heart surgery is important.


This item appears in the following Collection(s)

Show simple item record